Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery
Laurène Meyniel‐Schicklin, Jérôme Amaudrut, Pierre Mallinjoud et al. · Proceedings of the National Academy of Sciences · 2024
We present a drug design strategy based on structural knowledge of protein-protein interfaces selected through virus-host coevolution and translated into highly potential small molecules. This approach is grounded on Vinland, the most comprehensive atlas of virus-human protein-protein interactions with annotation of interacting domains. From this inspiration, we identified small viral protein domains responsible for interaction with human proteins. These peptides form a library of new chemical entities used to screen for replication modulators of several pathogens. As a proof of concept, a peptide from a KSHV protein, identified as an inhibitor of influenza virus replication, was translated into a small molecule series with low nanomolar antiviral activity. By targeting the NEET proteins, these molecules turn out to be of therapeutic interest in a nonalcoholic steatohepatitis mouse model with kidney lesions. This study provides a biomimetic framework to design original chemistries targeting cellular proteins, with indications going far beyond infectious diseases.
Cited by 4 works. doi:10.1073/pnas.2308776121
Authors
- Laurène Meyniel‐Schicklin
- Jérôme Amaudrut
- Pierre Mallinjoud
- Fabrice Guillier
- Laetitia Linès
- Anne Aublin‐Gex
- Caroline Scholtès
- Punginelli Claire
- Stéphane Joly
- Florence Vasseur
- Évelyne Manet
- Henri Gruffat
- Thomas Henry
- Farès Halitim
- Jean‐Laurent Paparin
- Peter J. Machin
- Raphaël Darteil
- Ivan Mikaélian
References
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- Error and attack tolerance of complex networks
- Error and attack tolerance of complex networks
- The igraph software package for complex network research
- DrugBank 5.0: a major update to the DrugBank database for 2018
- IntAct: an open source molecular interaction database
- A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
- Diagnosing the decline in pharmaceutical R&D efficiency
- SWISS-PROT: Connecting Biomolecular Knowledge Via a Protein Database